These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22470525)

  • 1. HDL proteome in hemodialysis patients: a quantitative nanoflow liquid chromatography-tandem mass spectrometry approach.
    Mangé A; Goux A; Badiou S; Patrier L; Canaud B; Maudelonde T; Cristol JP; Solassol J
    PLoS One; 2012; 7(3):e34107. PubMed ID: 22470525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein C-III in the high-density lipoprotein proteome of cerebral lacunar infarction patients impairs its anti-inflammatory function.
    Lv P; Zhao M; Liu Y; Jin H; Cui W; Fan C; Teng Y; Zheng L; Huang Y
    Int J Mol Med; 2018 Jan; 41(1):61-68. PubMed ID: 29115584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salutary effects of hemodialysis on low-density lipoprotein proinflammatory and high-density lipoprotein anti-inflammatory properties in patient with end-stage renal disease.
    Vaziri ND; Navab K; Gollapudi P; Moradi H; Pahl MV; Barton CH; Fogelman AM; Navab M
    J Natl Med Assoc; 2011 Jun; 103(6):524-33. PubMed ID: 21830637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal HDL apolipoprotein A-I and A-II kinetics in hemodialysis patients: a stable isotope study.
    Okubo K; Ikewaki K; Sakai S; Tada N; Kawaguchi Y; Mochizuki S
    J Am Soc Nephrol; 2004 Apr; 15(4):1008-15. PubMed ID: 15034103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis.
    Navarro JF; Mora C; Muros M; García-Idoate G
    Nephron Clin Pract; 2003; 95(4):c128-35. PubMed ID: 14694274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysfunctional high-density lipoprotein in patients on chronic hemodialysis.
    Yamamoto S; Yancey PG; Ikizler TA; Jerome WG; Kaseda R; Cox B; Bian A; Shintani A; Fogo AB; Linton MF; Fazio S; Kon V
    J Am Coll Cardiol; 2012 Dec; 60(23):2372-9. PubMed ID: 23141484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in lipoprotein composition in peritoneal dialysis patients.
    Moberly JB; Attman PO; Samuelsson O; Johansson AC; Knight-Gibson C; Alaupovic P
    Perit Dial Int; 2002; 22(2):220-8. PubMed ID: 11990407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased lipoprotein (a) and its relationships with other parameters of lipoprotein metabolism in chronic renal failure treated by hemodialysis.
    Yiğitoğlu MR; Polat MF; Akçay F; Ari Z; Uyanik BS; Ozilgili HM
    Jpn Heart J; 1997 Jan; 38(1):83-9. PubMed ID: 9186284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uremia alters HDL composition and function.
    Holzer M; Birner-Gruenberger R; Stojakovic T; El-Gamal D; Binder V; Wadsack C; Heinemann A; Marsche G
    J Am Soc Nephrol; 2011 Sep; 22(9):1631-41. PubMed ID: 21804091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic Characterization of High-Density Lipoprotein Particles from Non-Diabetic Hemodialysis Patients.
    Florens N; Calzada C; Delolme F; Page A; Guebre Egziabher F; Juillard L; Soulage ACO
    Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31731787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum non-high-density lipoprotein cholesterol (non-HDL-C) levels and cardiovascular mortality in chronic hemodialysis patients.
    Echida Y; Ogawa T; Otsuka K; Ando Y; Nitta K
    Clin Exp Nephrol; 2012 Oct; 16(5):767-72. PubMed ID: 22374049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dialysis Modalities and HDL Composition and Function.
    Holzer M; Schilcher G; Curcic S; Trieb M; Ljubojevic S; Stojakovic T; Scharnagl H; Kopecky CM; Rosenkranz AR; Heinemann A; Marsche G
    J Am Soc Nephrol; 2015 Sep; 26(9):2267-76. PubMed ID: 25745027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
    Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
    Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
    Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A.
    Tölle M; Huang T; Schuchardt M; Jankowski V; Prüfer N; Jankowski J; Tietge UJ; Zidek W; van der Giet M
    Cardiovasc Res; 2012 Apr; 94(1):154-62. PubMed ID: 22328092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biocompatible dialysis membranes and oxidative stress in patients wih end-stage renal disease on maintenance haemodialysis.
    Abdel-Naeem NM; Kandell NF; El-Shamaa AA; Harba TM; Abdel-Hady AA
    J Egypt Soc Parasitol; 2005 Dec; 35(3 Suppl):1173-97. PubMed ID: 16363293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Cluster of Proteins Implicated in Kidney Disease Is Increased in High-Density Lipoprotein Isolated from Hemodialysis Subjects.
    Shao B; de Boer I; Tang C; Mayer PS; Zelnick L; Afkarian M; Heinecke JW; Himmelfarb J
    J Proteome Res; 2015 Jul; 14(7):2792-806. PubMed ID: 26011469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pro-atherogenic HDL profile in coronary heart disease patients: an iTRAQ labelling-based proteomic approach.
    Yan LR; Wang DX; Liu H; Zhang XX; Zhao H; Hua L; Xu P; Li YS
    PLoS One; 2014; 9(5):e98368. PubMed ID: 24859250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of non-high-density lipoprotein cholesterol in hemodialyzed patients.
    Schreier L; González AI; Elbert A; Berg G; Wikinski R
    Metabolism; 2004 Aug; 53(8):1013-5. PubMed ID: 15281010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.